Our results indicate that, even if PAI-1, a major inhibitor of fibrinolysis, has higher concentrations in the plasma of patients with decompensated cirrhosis than in healthy individuals, this increase may not be sufficient to counterbalance the excessive tPA concentrations. This evidence concerns the gene PLAT and Cirrhosis.